Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with increased access to prenatal testing. SneakPeek, the #1 OBGYN-recommended ...
The top concern is that the next Trump presidency will cut funding. In many parts of Africa, such cuts could be critical for millions of girls and young women whose reproductive health and choices are ...